Top Industry Leaders in the Veterinary Clostridium Vaccine Market
Latest Veterinary Clostridium Vaccine Companies Updates:
Zoetis: Introduced an innovative combination vaccine, Suvaxyn One-Shot Plus, in October 2023, providing protection against multiple clostridial diseases in cattle with a single dose.
Merial: Received EU approval for their updated clostridial vaccine, Covexin 8, offering broader coverage against clostridial strains in sheep and goats in December 2023.
Boehringer Ingelheim: Announced the launch of their next-generation clostridial vaccine for poultry, Enterotox B, boasting enhanced protection against enterotoxemia in November 2023.
Ceva Animal Health: Investing in research to develop novel clostridial vaccines targeting emerging strains and addressing regional variations in disease prevalence.
Colorado Serum Company: Collaborating with academic institutions to explore the use of adjuvants and delivery systems for improved potency and immune response in clostridial vaccines.
MPLIPHI: Focused on developing affordable and accessible clostridial vaccines for resource-limited settings, contributing to improved animal health in developing countries.
List of Veterinary Clostridium Vaccine Key companies in the market:
- Merck & Co., Inc. (US)
- Ceva Santé Animale (France)
- Boehringer Ingelheim International GmbH (Germany)
- Colorado Serum Company (US)
- Virbac (Australia)
- Valneva SE (France)
- Zoetis (US)
- Elanco Animal Health (US)
- Bayer AG (Germany)